CombiMatrix hires new chief medical officer
This article was originally published in Clinica
Executive Summary
Prenatal and pediatric molecular diagnostics specialist CombiMatrix has appointed Dr Weslie Tyson chief medical officer, effective 8 April. He replaces Dr Richard Hockett, who resigned on 19 February for “personal reasons” according to a filing with the US Securities and Exchange Commission (SEC). New CMO Dr Tyson has been a practising pediatric and perinatal pathologist for 24 years, and previously worked for UniPath, a multispecialty pathology group, since 2009.